Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.
about
Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cellsExpression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis.Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer.Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.Effects of resistin-like molecule β over-expression on gastric cancer cells in vitro.MMP2 and MMP7 at the invasive front of gastric cancer are not associated with mTOR expressionCCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patientsClinical impact of MMP and TIMP gene polymorphisms in gastric cancer.Stomach Cancer: Interconnection between the Redox State, Activity of MMP-2, MMP-9 and Stage of Tumor GrowthMolecular staging of gastric cancer.Changes of histology and expression of MMP-2 and nm23-H1 in primary and metastatic gastric cancer.XB130 promotes proliferation and invasion of gastric cancer cellsTissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review.The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis.MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is notEffect of CO2 pneumoperitoneum on the proliferation of human ovarian cancer cell line SKOV-3 and the expression of NM23-H1 and MMP-2.Effects of legumain as a potential prognostic factor on gastric cancers.Proteolysis in Helicobacter pylori-Induced Gastric Cancer.Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer.Matrix metalloproteinase-2 expression in stromal tissues is a consistent prognostic factor in stage II colon cancer.Matrix metalloproteinase-14 is a negative prognostic marker for patients with gastric cancer.MMP-2 is a disease-modifying gene in primary sclerosing cholangitis.Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis.Immunoexpression of metalloproteinases 2 and 14 and TIMP-2 inhibitor in main types of primary gastric carcinomas and lymph node metastasis.Molecular aspects in the diagnosis of gastric cancer.IGF-1-induced MMP-11 expression promotes the proliferation and invasion of gastric cancer cells through the JAK1/STAT3 signaling pathway.
P2860
Q33529871-395CF86F-D83D-49B4-80DD-B76B0347DD4AQ33756272-8801F043-57D4-4A53-95B8-AE967E8D5755Q33952599-5663463C-C72C-4A3C-BF04-3446C4708FEEQ34992987-9EAF88DA-CCB4-486B-B8A0-862E697B43E4Q35616512-9B5D0378-C673-456D-B7EC-018B11D75194Q35776104-D985C4A9-58B6-48F8-A03F-C693D30A29A5Q36366058-73F06599-9420-44C6-9C54-3A0299654106Q36498098-F6F5684F-0587-4746-8C94-EAADC5A22EBBQ36610882-92662650-B22A-486C-A0CB-FC6B2B0A2AC4Q36611620-AEC5CB3B-2A69-45E5-AA40-831A570142BDQ36828631-7EDA29F7-FA76-47DE-B66D-5CBC629AE2A6Q36940064-91F48D4E-5B4B-4F2B-9BB3-8103AE767B66Q37220911-8657B245-971A-4025-85CE-2169C41691E2Q37441280-9D9E8A82-81BD-456D-AF2D-2DC678A9985CQ38119975-344EF118-EB8A-466F-A5FF-27F93D6D0FE3Q38194507-9FFED958-2893-4851-996E-6F807B06C69DQ38805508-912A830D-8C20-4084-A180-436E427496ADQ38964304-77E9EECC-B954-4E01-9385-A01683298BD2Q39143545-F42219EE-0128-4261-9251-E61A74B014BBQ39234154-0B187FA0-BB18-4D06-8B2B-70A89D07AA3BQ39790504-D87607AF-45D4-47F3-B488-D31FB91E1220Q39851004-B1F088D3-140B-43CC-9076-702241C7E11EQ45091889-39EE511B-6CF4-4BF7-A071-70921238A0DAQ46214642-7EBA581D-9DE9-43FA-A65F-DFBFB39E74A3Q48217437-F00876B0-E64A-4B66-910D-8580CC1B2AC6Q51141692-C7B74F1B-1FF5-4835-ACC2-6C40ADE2CE29Q53307075-23D30455-C87E-4834-8BBD-90BA6181F0CBQ54966335-C2E30804-4681-47CB-B789-3A7D5DDB349A
P2860
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.
@ast
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.
@en
type
label
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.
@ast
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.
@en
prefLabel
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.
@ast
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.
@en
P2093
P2860
P356
P1476
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.
@en
P2093
C B H W Lamers
C F M Sier
C J H van de Velde
F J G M Kubben
G Griffioen
H W Verspaget
J H J M van Krieken
R Hanemaaijer
W van Duijn
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603041
P407
P577
2006-04-01T00:00:00Z
P5875
P6179
1049724575